|Mr. Oleg Movchan||Interim CEO & Director||N/A||N/A||1975|
|Mr. Stephen Malherbe||Managing Partner||N/A||N/A||N/A|
|Mr. Stephen P. Dorton||Chief Financial Officer||N/A||N/A||1966|
|Mr. Michael Berry||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Alan Polo||Head of Account Management||N/A||N/A||N/A|
|Mr. Daniel Groman||Chief Technology Officer||N/A||N/A||1989|
|Mr. Brian Murphy||Investor||N/A||N/A||N/A|
|Ms. Lorelei M. Skillman||Chief Marketing & Communications Officer||N/A||N/A||1970|
|Ms. Bronwen Bastone||Chief People Officer||N/A||N/A||1973|
|Mr. Kabir Kohli||MD of Managed Services Solutioning & Global Head of Client Services||N/A||N/A||N/A|
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Enfusion, Inc.s ISS Governance QualityScore, Stand 1. Oktober 2022, lautet 9. Die grundlegenden Scores sind Audit: 7, Vorstand: 10, Shareholderrechte: 8, Kompensation: 9.